Signaling by insulin receptors and related protein tyrosine kinases

Biomedical Reviews

Volumn 5, Issue , 1996, Pages 5-30

  Ouwens, D Margriet ^a   Maassen, J Antonie ^a,b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN RECEPTOR; INSULIN RECEPTOR KINASE; PROTEIN TYROSINE KINASE;

RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION;

SIGANUS;

EID: 0029805328     PISSN: 1310392X     EISSN: None     Source Type: Journal    
DOI: 10.14748/bmr.v5.180     Document Type: Review

References (150)

1. Ullrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 1990; 61: 203-212
2. Van der Geer P, Hunter T, Lindberg RA. Receptor proteintyrosine kinases and their signal transduction pathways. Annu Rev Cell Biol 1994; 10: 251-337
3. Hanks SK, Quinn AM, Hunter T. The protein tyrosine kinase family: conserved features and deduced phytogeny of the catalytic domains. Science 1988; 241: 42-52
4. Hunter T. Protein kinase classification. Meth Enzymol 1991; 200: 3-37
5. Downward J, Yarden Y, Mayes E, Scarce G, Totty N, Stockwell P et al. Close similarity of epidermal growth factor receptor and v-erbB oncogene protein sequences. Nature 1984; 307: 521-527
6. Ullrich A, Coussens L, Hayflick JS, Dull TJ, Gray A, Tam AW et al. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 1984; 309: 418-425
7. Ullrich A, Bell JR, Chen EY, Herrera R, Petruzelli LM, Dull TJ et al. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature 1985; 313: 756-761
8. Ebina Y, Ellis L, Jarnagin K, Edery M, Graf L, Clauser E et al. The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signaling. Cell 1985; 40: 747-758
9. Kahn CR. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 1994; 43: 1066-1084
10. Taylor SI, Cama A, Accili D, Barbetti F, Quon MJ, de la Luz Sierra M et al. Mutations in the insulin receptor gene. Endocr Rev 1992; 13: 566-595
11. Ullrich A, Gray A, Tam AW, Yang-Fen T, Tsubokawa M, Collins C et al. Insulin-like growth factor-1 receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J 1986; 5: 2503-2512
12. Lund PK. Insulin-like growth factor-1: Molecular biology and relevance to tissue specific expression and action. Rec Prog Horm Res 1994; 49: 49-148
13. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor-1 (IGF-1) and type 1 IGF receptor (IGF-1R). Cell 1993; 75: 59-72
14. Yarden Y, Escobedo JA, Kuang WJ, Yang-Feng TL, Daniel TO, Tremble PM et al. Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors. Nature 1986; 323: 226-232
15. Jaye M, Schlessinger J, Dionne CA. Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction. Biochim Biophys Acta 1992; 1135:185-199
16. Fong GH, Rossant J, Gertsenstein M, Breitman ML. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995; 376:66-70
17. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML et al. Failure of blood island formation and vasculogenesis in Flk-1 deficient mice. Mature 1995; 376: 62-66
18. Arumäe U. Neurotrophins: neural antiapoptotic molecules with neurite growth-promoting properties. Biomed Rev 1995; 4: 15-27
19. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M et al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 1995; 376: 70-74
20. Schuchardt A, D'Agati V, Larsson-Blomberg L, Constantini F, Pachis V. Defects in the kidney and enteric nervous system in mice lacking the tyrosine receptor Ret. Nature 1994; 367: 380-383
21. Lemmon MA, Schlessinger J. Regulation of signal transduction and signal diversity by receptor oligomerization. Trends Biochem Sci 1994; 19: 459-463
22. Heldin CH. Dimerization of cell surface receptors in signal transduction. Cell 1995; 80: 213-223
23. Schlessinger J, Lax I, Lemmon M. Regulation of growth factor activation by proteoglycans: What is the role of the low-affinity receptors ? Cell 1995; 83: 357-360
24. Tessier-Lavigne M. Eph receptor tyrosine kinases, axon repulsion, and the development of topographic maps. Cell 1995; 82: 345-348
25. Hanks SK. Eukaryotic protein kinase. Curr Biol 1991; 1: 369-383
26. Hanks SK, Quinn AM. Protein kinase catalytic domain sequence database: identifcation and classification of family members. Meth Enzymol 1991; 200: 38-62
27. Hubbard SR, Wei L, Ellis L, Hendrickson WA. Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature 1994; 372: 746-753
28. Knighton DR, Zheng J, Ten Eyck LF, Ashford VA, Xuong NH, Taylor SS et al. Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science 1991; 253: 407-414
29. Pawson T, Gish GD. SH2 and SH3 domains: from structure to function. Cell 1992; 71: 359-362
30. Pawson T, Schlessinger J. SH2 and SH3 domains. Curr Biol 1993; 3: 434-442
31. Cohen GB, Ren R, Baltimore D. Modular binding domains in signal transduction proteins. Cell 1995; 80: 237-248
32. Bork P, Margolis B. A phosphotyrosine interaction domain. Cell 1995; 80: 693-694
33. Musacchio A, Gibson T, Rice P, Thompson J, Saraste M. The PH domain: a common piece in the structural pathwork of signalling proteins. Trends Biochem Sci 1993; 18: 343-348
34. Gibson TJ, Hyvönen M, Musacchio A, Saraste M, Birney E. PH domain: the first anniversary. Trends Biochem Sci 1994; 19: 349-353
35. Mayer BJ, Ren R, Clark KL, Baltimore D. A putative modula domain present in diverse signaling proteins. Cell 1993; 73: 629-630
36. Haslam RJ, Koide HB, Hemmings BA. Pleckstrin domain homology. Nature 1993; 363: 309-310
37. Koch CA, Anderson D, Moran MF, Ellis C, Pawson T. SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science 1991; 252: 668-674
38. Mayer BI, Jackson PK, Baltimore D. The non-catalytic src homology region 2 segment of abl tyrosine kinase binds to tyrosine phosphorylated cellular proteins with high affinity. Proc Natl Acad Sci USA 1991; 88:627-631
39. Anderson D, Koch CA, Grey L, Ellis C, Moran MF, Pawson T. Binding of SH2 domains of phospholipase C gamma 1, GAP, and Src to activated growth factor receptors. Science 1990; 250: 979-982
40. Fantl WJ, Escobedo JA, Martin GA, Turck CW, del Rosario M, McCormick F et al. Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathways. Cell 1992; 69: 413-423
41. Kuriyan J, Cowburn D. Structures of SH2 and SH3 domains. Curr Biol 1993; 3:828-837
42. Waksman G, Kominos D, Robertson SC, Pant N, Baltimore D, Birge RB et al. Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine phosphorylated peptides. Nature 1992; 358: 646-653
43. Waksman G, Shoelson SE, Pant N, Cowburn D, Kuriyan J. Binding of high affinity phosphotyrosyl peptide to the Src SH2 domain: crystal structures of the complexed and peptide-free forms. Cell 1993; 72: 779-790
44. Eck MJ, Shoelson SE, Harrison SC. Recognition of a high affinity phosphotyrosyl peptide by the Src homology-2 domain of p561ck. Nature 1993; 362: 87-91
45. Booker GW, Breeze AL, Downing AK, Panayotou G, Gout I, Waterfield MD et al. Structure of an SH2 domain of the p85α subunit of phosphatidylinositol-3-OH kinase. Nature 1992; 358: 684-687
46. Overduin MD, Rios CB, Mayer BJ, Baltimore D, Cowburn D. 3-Dimensional solution structure of the src homology-2 domain of c-Abl. Cell 1992; 70: 697-704
47. Overduin MD, Mayer B, Rios CB, Baltimore D, Cowburn D. Secondary structure of the Src homology 2 domain of c-Abl by heteronuclear NMR spectroscopy in solution. Proc Natl Acad Sci USA 1992; 89: 11673-11677
48. Songyang Z, Shoelson SE, Chaudhuri M, Gish G, Pawson T, Haser W et al. SH2 domains recognize specific phosphopeptide sequences. Cell 1993; 72: 767-778
49. Songyang Z, Shoelson SE, McGlade J, Olivier P, Pawson T, Bustelo XR et al. Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav. Mol Cell Biol 1994; 14: 2777-2785
50. Gustafson TA, He W, Craparo A, Schaub CD, O'Neill TJ. Phosphotyrosine-dependent interaction of Shc and insulin receptor substrate-1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain. Mol Cell Biol 1995; 15: 2500-2508
51. Kavanaugh WM, Williams LT. An alternative to SH2 domain for binding tyrosine phosphorylated proteins. Science 1994; 266: 1862-1865
52. Sun XJ, Wang LM, Zhang Y, Yenush L, Myers MG, Glasheen E et al. Role of IRS-2 in insulin and cytokine signalling. Nature 1995; 377: 173-177
53. Musacchio A, Noble M, Pauptit R, Wierenga R, Saraste M. Crystal structure of a Src-homology 3 (SH3) domain. Nature 1992; 359: 851-855
54. Noble MEM, Musacchio A, Saraste M, Courtneidge SA, Wierenga RK. Crystal structure of the SH3 domain in human fyn - comparison of the 3-dimensional structures of SH3 domains in tyrosine kinases and spectrin. EMBO J 1993; 12: 2617-2624
55. Yu H, Rosen MK, Shin TB, Seidel-Dugan C, Brugge JS, Schreiber SL. Solution structure of the SH3 domain of Src and identification of its ligand-binding site. Science 1992; 258: 1665-1668
56. Booker GW, Gout I, Downing AK, Driscoll PC, Boyd J, Waterfield MD et al. Solution structure and ligand-binding site of the SH3 domain of the p85-alpha subunit of phosphatidylinositol 3-kinase. Cell 1993; 73: 813-822
57. Kohda D, Hatanaka H, Odaka M, Mandiyan V, Ullrich A, Schlessinger J et al. Solution structure of the SH3 domain of phospholipase C-gamma. Cell 1993; 72: 953-960
58. Ren R, Mayer BJ, Cicchetti P, Baltimore D. Identification of a ten-amino acid proline-rich SH3 binding site. Science 1993; 259: 1157-1161
59. Yu H, Chen JK, Feng S, Dalgarno DC, Brauer AW, Schreiber SL. Structural basis for the binding of proline-rich peptides to SH3 domains. Cell 1994; 76: 933-945
60. Inglese J, Koch WJ, Touhara K, Lefkowitz RJ. Gβγ interactions with PH domains and Ras-MAPK signaling pathways. Trends Biochem Sci 1995; 20: 151-156
61. Ferguson KM, Lemmon MA, Schlessinger J, Sigler PB. Crystal structure at 2.2 Å resolution of the pleckstrin homology domain from human dynamin. Cell 1994; 79: 199-209
62. Harlan JE, Hajduk PJ, Yoon HS, Fesik SW. Pleckstrin homology domains bind to phosphatidylinositol-4,5-bisphosphate. Nature 1994; 371: 168-170
63. Songyang Z, Cantley LC. Recognition and specificity in protein tyrosine kinase-mediated signalling. Trends Biochem Sci 1995; 20: 470-475
64. Lowy DR, Willumsen BM. Function and regulation of ras. Annu Rev Biochem 1993; 62: 851-893
65. Bourne HR, Sanders DA, McCormick F. The GTPase superfamily: conserved structure and molecular mechanism. Nature 1991; 349: 117-127
66. Hall A. The cellular function of small GTP binding proteins. Science 1990; 249: 635-640
67. Bos JL. Ras oncogenes in human cancer: a review. Cancer Res 1989; 49:4682-4689
68. Bollag G, McCormick F. Regulators and effectors of ras proteins. Annu Rev Cell Biol 1991; 7: 601-632
69. ras in fibroblasts. Mol Cell Biol 1993; 13: 1903-1910
70. ras. Mol Cell Biol 1993; 13: 155-162
71. Bowtell D, Fu P, Simon M, Senior P. Identification of murine homologues of the Drosophila Son of sevenless gene: potential activators of ras. Proc Natl Acad. Sci USA 1992; 89: 6511-6515
72. Lowenstein EJ, Daly RJ, Batzer AG, Li W, Margolis B, Lammers R et al. The SH2 and SH3 domain-containing proteins GRB2 links receptor tyrosine kinases to ras signalling. Cell 1992; 70: 431-442
73. Clark SG, Stern MJ, Horvitz HR. C. elegans cell signaling gene sem-5 encodes a protein with SH2 and SH3 domains. Nature 1992; 356: 340-344
74. Olivier JP, Raabe T, Henkemeyer M, Dickson B, Mbamalu G, Margolis B et al. A Drosophila SH2-SH3 adaptor protein implicated in coupling the sevenless tyrosine kinase to an activator of ras guanine nucleotide exchange, Sos. Cell 1993; 73: 179-191
75. ras1 activation and binds to sevenless and Sos proteins in vitro. Cell 1993; 73: 169-177
76. Gale NW, Kaplan S, Lowenstein EJ, Schlessinger J, Bar-Sagi D. Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on Ras. Nature 1993; 363: 88-92
77. Skolnik EY, Batzer A, Li N, Lee CH, Lowenstein E, Mohammadi M et al. The function of Grb2 in linking the insulin receptor to ras signaling pathways. Science 1993; 260: 1953-1955
78. ras through the formation of a complex of receptor, grb2 adapter protein, and SOS nucleotide exchange factor. Cell 1993; 73: 611-620
79. Chardin P, Camonis JH, Gale NW, Van Aelst L, Schlessinger J, Wigler MH et al. Human Sos1: a guanine nucleotide exchange factor for Ras that binds to grb2. Science 1993; 260: 1338-1343
80. Egan SE, Giddings BW, Brooks MW, Buday L, Sizeland AM, Weinberg RA. Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature 1993; 363: 45-51
81. Li N, Batzer A, Daly R, Yajnik V, Skolnik E, Chardin P et al. Guanine nucleotide-releasing factor hSOS1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling. Nature 1993; 363: 85-88
82. Rozakis-Adcock M, Fernely R, Wade J, Pawson T, Bowtell D. The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSOS1. Nature 1993; 363: 83-85
83. Pellici G, Lanfrancone L, Grignani F, McGlade J, Cavallo F, Forni G et al. A novel transforming protein (Shc) with an SH2 domain is implicated in mitogenic signal transduction. Cell 1992; 70: 93-104
84. Rozakis-Adcock M, McGlade J, Mbamalu G, Pellici G, Daly R, Schlessinger J et al. Association of the Shc and Grb2/Sem-5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature 1992; 360: 689-692
85. Boguski MS, McCormick F. Proteins regulating Ras and its relatives. Nature 1993; 366: 643-654
86. Davis RJ. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 1993; 268: 14553-14556
87. Vojtek AB, Hollenberg SM, Cooper JA. Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell 1993; 74: 205-214
88. ras proteins bind to the amino-terminal regulatory domain of c-Raf-1. Nature 1993; 364: 308-313
89. Warne PH, Rodriguez-Viciana P, Downward J. Direct interaction of Ras and the amino-terminal region of raf-1 in vitro. Nature 1993; 364: 352-355
90. McCormick F. Raf: the holy grail of Ras biology ? Trends Cell Biol 1994; 4: 347-350
91. Leevers SJ, Paterson HF, Marshall CJ. Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane. Nature 1994; 369: 411-414
92. Stokoe D, MacDonald SG, Cadwallader K, Symons M, Hancock JF. Activation of Raf as a result of recruitment to the plasma membrane. Science 1994; 264: 1463-1467
93. Kyriakis JM, App H, Zhang XF, Banerjee P, Brautigan DL, Rapp UR et al. Raf-1 activates MAP kinase kinase. Nature 1992; 358: 417-421
94. Alessi DR, Saito Y, Campbell DC, Cohen P, Sithanandam G, Rapp U et al. Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1. EMBO J 1994; 13: 1610-1619
95. Zheng CF, Guan KL. Activation of MEK family kinases requires phosphorylation of two conserved Ser/Thr residues. EMBO J 1994; 13: 1123-1131
96. Marshall CJ. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-related kinase activation. Cell 1995; 80: 179-185
97. Waters SB, Holt KH, Ross SE, Syu LJ, Guan KL, Saltiel AR et al. Desensitization of Ras activation by a feed back dissociation of the Sos/Grb2 complex. J Biol Chem 1995; 270: 20883-20886
98. Davis RJ. MAPKs: new JNK expands the group. Trends Biochem Sci 1994; 19: 470-473
99. Coso OA, Chiariello M, Yu JC, Teramoto H, Crespo P, Xu N et al. The small GTP-binding prteins Rac1 and cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell 1995; 81: 1137-1146
100. Minden A, Lin A, Claret FX, Abo A, Karin M. Selective activation of the JNK signaling cascade and c-jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell 1995; 81: 1147-1157
101. Gibbs JB, Schaber MD, Allard WJ, Sigal IS, Scolnick EM. Purification of ras GTPase activating protein from bovine brain. Proc Natl Acad Sci USA 1988; 85: 5026-5030
102. Trahey M, McCormick F. A cytoplasmic protein stimulates normal N-ras p21GTPase but does not affect oncogenic mutants. Science 1987; 238: 542-545
103. ras upon T-cell activation. Nature 1990; 346: 719-723
104. Ellis C, Moran M, McCormick F, Pawson T. Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases. Nature 1990; 343: 377-381
105. + channel currents. Science 1992; 255: 192-194
106. Medema RH, de Laat WL, Martin GA, McCormick F, Bos JL. GTPase activing protein SH2-SH3 domains induce gene expression in a Ras dependent fashion. Mol Cell Biol 1992; 12: 3425-3430
107. Wong G, Müller O, Clark R, Conroy L, Moran MF, Polakis P et al. Molecular cloning and nucleic acid binding of the GAP-associated tyrosine phosphoprotein p62. Cell 1992; 69: 551-558
108. Settleman J, Narasimhan V, Foster LC, Weinberg RA. Molecular cloning of cDNAs encoding GAP-associated protein p190: implications for a signaling pathway from Ras to the nucleus. Cell 1992; 69: 539-549
109. Settleman J, Albright CF, Foster LC, Weinberg RA. Association between GTPase activators for Rho and Ras fiunilies. Nature 1992; 359: 153-154
110. McGlade J, Brunkhorst B, Anderson D, Mbamalu G, Settlleman J, Dedhar S et al. The N-terminal region of GAP regulates cytoskeletal structure and cell adhesion. EMBO J 1993; 12: 3073-3081
111. Dhand R, Hiles I, Panayotou G, Roche S, Fry MJ, Gout I et al. PI 3-kinase is a dual-specificity enzyme: autoregulationby an intrinsic protein-serine kinase activity. EMBO J 1994; 13: 522-533
112. Hunter T. When is a lipid kinase not a lipid kinase ? When it is a protein kinase. Cell 1995; 83: 1-4
113. Fry MJ, Waterfield MD. Structure and function of phosphatidylinositol 3-kinase: a potential second messenger system involved in growth control. Phil Trans R Soc Lond B 1993; 340: 337-344
114. Valius M, Kazlauskas A. Phospholipase C-gamma 1 and phosphatidylinositol 3 kinase are the downstream mediators of the PDGF receptor's mitogenic. Cell 1993; 74: 321-334
115. Cheatham B, Vlahos CJ, Cheatham L, Wang L, Blenis J, Kahn CR. Phosphatidylinositol 3-kinase is required for insulin stimulation of pp70 S6 kinase, DNA synthesis and glucose transporter translocation. Mol Cell Biol 1994; 14: 4902-4911
116. Bos JL. A target for phosphoinositide 3-kinase: Akt/PKB. Trends Biochem Sci 1995; 20: 441-442
117. Chung J, Grammar TC, Lemon KP, Kazlauskas A, Blenis J. PDGF-dependent regulation of pp70-S6 kinase is coupled to receptor-dependent binding and activation of phosphatidylinositol 3-kinase. Nature 1994; 370: 71-75
118. Downward J. Regulating S6 kinase. Nature 1994; 371: 378-379
119. Bar Sagi D, Rotin D, Batzer A, Mandiyan V, Schlessinger J. SH3 domains direct cellular localization of signaling molecules. Cell 1993; 74: 83-91
120. Hunter T. Protein tyrosine phosphatases: the other side of the coin. Cell 1989; 58: 1013-1016
121. Mourey RJ, Dixon JE. Protein tyrosine phosphatases: characterization of extracellular and intracellular domains. Curr Opin Genet Dev 1994; 4: 31-39
122. Shen SH, Bastien L, Posner BI, Chretien P. A protein tyrosine phospahatase with sequence similarity to the SH2 domain of the protein tyrosine kinases. Nature 1991; 352: 736-739
123. Vogel W, Lammers R, Huang J, Ullrich A. Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation. Science 1993; 259: 1611-1614
124. Bennet AM, Tang TL, Sugimoto S, Walsh CT, Neel BG. Protein tyrosine phosphatase SHPTP2 couples platelet derived growth factor beta to Ras. Proc Natl Acad Sci USA 1994; 91: 7335-7339
125. Li W, Nishimura R, Kashishian A, Batzer AG, Kim WJ, Cooper JA et al. A new function for a phosphotyrosine phosphatase: linking Grb2-Sos to a receptor tyrosine kinase. Mol Cell Biol 1994; 14: 509-517
126. Noguchi T, Matozaki T, Horita K, Fujijoka Y, Kasuga M. Role of SH-PTP2, a protein tyrosine phosphatase with Src homology 2 domains in insulin-stimulated Ras activation. Mol Cell Biol 1994; 14: 6674-6682
127. Yamauchi K, Milarski KL, Saltiel AR, Pessin J. Protein tyrosine phosphaste SH-PTP2 is a required positive effector of insulin downstream signaling. Proc Natl Acad Sci USA 1995; 92: 664-668
128. Cantley LC, Auger KR, Carpenter C, Duckworth B, Graziani A, Kapeller R et al. Oncogenes and signal transduction. Cell 1991; 64: 281-302
129. Courtneidge SA, Fumagalli S. A mitotic function for Src? Trends Cell Biol 1994; 4: 345-347
130. Shenoy S, Chachalaparampil I, Bagrodia S, Lin PH, Shalloway D. Role of p34cdc2-mediated phosphorylations in two step activation of pp60-c-src during mitosis. Proc Natl Acad Sci USA 1992; 89: 7237-7241
131. Hanks SK, Calalb MB, Harper MC, Patel SK. Focal adhesion protein tyrosine kinase phosphorylated in response to cell spreading on fibronectin. Proc Natl Acad Sci USA 1992; 89: 8487-8489
132. FAK, a structurally unique protein kinase associated with focal adhesions. Proc Natl Acad Sci USA 1992; 89:5192-5196
133. Schwartz MA, Schaller MD, Ginsberg MH. Integrins: emerging paradigms of signal transduction. Annu Rev Cell Biol 1995; 11: 549-599
134. Clark EA, Brugge JS. Integrins and signal transduction pathways: the road taken. Science 1995; 268: 223-229
135. Jokusch BM, Bubeck P, Giehl K, Kroemker M, Moschner J, Rothkegel M et al. The molecular architecture of focal adhesions. Annu Rev Cell Biol 1995; 11: 379-416
136. White MF, Shoelson SE, Keutmann H, Kahn CR. A cascade of tyrosine phosphorylation in the beta-subunit activates the phosphotransferase of the insulin receptor. J Biol Chem 1988; 263: 2969-2980
137. Tornqvist HE, Pierce MW, Frackelton HR, Nemenoff RA, Avruch I. Identification of the insulin receptor tyrosine residues autophosphorylated in vitro. J Biol Chem 1987; 262: 10212-10219
138. Tornqvist HE, Gunsalus JR, Nemenoff RA, Frackelton RA, Pierce MW, Avruch J. Identifcation of the insulin receptor tyrosine residues undergoing insulin-stimulated phosphorylation in intact rat hepatoma cell. J Biol Chem 1988; 263: 350-359
139. Sun XJ, Rothenberg P, Kahn CR, Backer JM, Araki E, Wilden PA et al. Structure of the insulin receptor substrate (IRS-1) defines an unique signal transduction protein. Nature 1991; 352: 73-77
140. Pronk GJ, McGlade J, Pelicci G, Pawson T, Bos JL. Insulin-induced phosphorylation of the 46 and 52 kD Shc proteins. J Biol Chem 1993; 268: 5748-5753
141. ras activation. EMBO J 1991; 10: 1103-1109
142. ras-GTP formation. J Biol Chem 1994; 269: 33116-33122
143. ras. Mol Cell Biol 1994; 14: 1575-1581
144. rasGTP formation. J Biol Chem 1994; 269: 10734-10738
145. Van den Berghe N, Ouwens DM, Maassen JA, van Mackelenbergh MGH, Sips HCM, Krans HMJ. Activation of the Ras/mitogen activated protein kinase signaling pathway alone is not sufficient to induce glucose uptake in 3T3L1 adipocytes. Mol Cell Biol 1994; 14: 2372-2377
146. ras in activation of extracellular signal regulated kinase 2. Nature 1992; 357: 602-605
147. Dorrestijn J, Ouwens DM, van den Berghe N, Bos JL, Maassen JA. Expression of a dominant-negative Ras mutant does not affect stimulation of glucose uptake and glycogen synthesis by insulin. Diabetologia 1996; 39: In press
148. Pillay TS, Sasaoka T, Olefsky JM. Insulin stimulates the tyrosine dephosphorylation of pp125 Focal Adhesion Kinase. J Biol Chem 1995; 270: 991-994
149. Ouwens DM, Mikkers HMM, van der Zon GCM, Stein-Gerlach M, Ullrich A, Maassen JA. Insulin-induced tyrosine dephosphorylation of focal adhesion kinase and paxillin requires active phosphotyrosine phosphatase 1D. Submitted for publication
150. Ouwens DM, van der Zon GCM, Maassen JA. Unpublished observation